Francesca Khani, MD

Associate Professor of Pathology, Weill Cornell Medicine. Specializing in Urologic pathology. #gupath Opinions/views are my own.

[Francesca Khani, MD @FKhaniPath]

@HimanshuNagarMD @seanmmcbride @rovingatuscap Simple question- difficult answer! Definition of “cribriform” and thresholds for mentioning it in pathology reports are quite variable among pathologists, (including among GU experts,) and between institutions.

[American Academy of Pediatrics @AmerAcadPeds]

Pediatricians do not profit off vaccines. In fact, most pediatricians either break even or even lose money when they offer vaccines. Misleading parents about doctors' motivations puts children's health at risk and sows distrust in lifesaving vaccinations.
https://t.co/BmRlh6wx1G

[Karen Sfanos @sfanoslab]

Sometimes you just need to stand up and say something. https://t.co/GHRdcCyqTn via @HubJHU

[Francesca Khani, MD @FKhaniPath]

https://t.co/95PK4gV35r

[Francesca Khani, MD @FKhaniPath]

@SalamonSMD @jjfitzgeraldMD Pathologist here- confirming that no extra stains/markers needed, as endometrial glands and stroma are easily seen on routine H&E preparation. If we see endometrial tissue in a location outside the uterus, it is endometriosis.

[Francesca Khani, MD @FKhaniPath]

@AshleyGWinter @amac25 Me too! Huge fan of daycare!

[Francesca Khani, MD @FKhaniPath]

@clhubes Also with an infant and toddler here, and I tell myself I’m going to do this every night but still haven’t yet. So… I think maybe it’s not possible.

[Francesca Khani, MD @FKhaniPath]

@moira_here @AshleyGWinter Yes, thank you @AshleyGWinter for taking a stand! No legitimate medical organization should be holding conferences in these states. But especially given that urologists often play a major role in reproductive medicine/IVF, the AUA @AmerUrological should be more mindful of this.

[Weill Cornell Medicine Pathology @WCMCPathology]

Big audience last night @TheUSCAP for "Morphologic Mysteries of the Stomach: Guess the Gastritis," presented by @WCMCPathology's Dr. Annika L. Windon (@AWindonMD)! #USCAP2024 #IAMUSCAP #Pathology #PathTwitter

[Francesca Khani, MD @FKhaniPath]

And thank you @GU_Path_Society for inviting me! Had a lot of fun giving the talk! #USCAP2024

[Samson W. Fine, MD @rovingatuscap]

Thanks again to the wonderful panel @Williamson_SR @FKhaniPath @BehfarEhdaieMD and moderators @FionaMacPath @LotanLab for yesterday’s @GU_Path_Society Companion Society Meeting #USCAP2024 - synthesized knowledge & fresh thinking 💭 made it a success!

[Francesca Khani, MD @FKhaniPath]

This is the hill I’m willing to die on so to speak…. here’s another article with sound, evidence-based arguments. #gupath

[Matthew Wasco @Gleason4plus5]

Another commentary on reasons for not renaming 3+3 as "not cancer" - this from Dr Samaratunga et al. Hits on several important points #gupath

https://t.co/XZQ2SM5tCS

[Francesca Khani, MD @FKhaniPath]

@Gleason4plus5 @rovingatuscap I only apply the “significant cytologic atypia” criterion for when the architecture of the intraductal proliferation is micropapillary (as opposed to dense cribriform), and if there isn’t necrosis. Marked cytologic atypia is what would distinguish IDC from micropapillary PIN.

[Francesca Khani, MD @FKhaniPath]

@anusubram It is outrageous that insurance companies are dragging their feet with this…don’t they realize it would be better to pay the few hundred dollars for a vaccine/monoclonal antibody vs paying multiple thousands of dollars for potential inpatient/ICU admission due to RSV?

[Francesca Khani, MD @FKhaniPath]

Congrats @ErikaHissong on this work! @WCMCPathology #gipath

[Pashtoon Kasi MD, MS @pashtoonkasi]

🗞️@Forbes Published today!

Are we on the verge of a new drug combo for colorectal cancer?

Read more about our work on this immunotherapy called the BOT (Botensilimab).

We describe this “inside-out”🌊 wave of regression by immune cells. @TheAlexKnapp

https://t.co/ccGLVZ8nwa

[Pashtoon Kasi MD, MS @pashtoonkasi]

🗞️@Forbes Published today!

Are we on the verge of a new drug combo for colorectal cancer?

Read more about our work on this immunotherapy called the BOT (Botensilimab).

We describe this “inside-out”🌊 wave of regression by immune cells. @TheAlexKnapp

https://t.co/ccGLVZ8nwa

[Francesca Khani, MD @FKhaniPath]

This was a great team effort with amazing leadership from @mishabeltran and @notSoJunkDNA. And big thanks to all collaborators for their various contributions!

[Nicolas Robine @notSoJunkDNA]

We (@nygenome cancer compbio group) are very fortunate to work closely with @WCMEnglanderIPM and have several papers in preparation. Here is one focused on brain metastases in prostate cancer with @FKhaniPath @willbfx @mishabeltran
https://t.co/v7rT6XQV3v

[Andrea Apolo, M.D. @apolo_andrea]

@h_alahmadie discusses molecular characteristics of rare variants and mixed histologies #BCATT23 working group on RARE VARIANT SUBTYPES OF #BLADDERCANCER lead by @BladderCancerUS #BladderCancer

[Andrea Apolo, M.D. @apolo_andrea]

@FKhaniPath reviews rare #BladderCancer aggressive variants including micropapillary, plasmacytoid, & sarcomatoid, WHO updates, & treatment implications. Thanks for the @ALLIANCE_org #ICONIC trial shout out. We need help enrolling these rare variants #BCATT23 @BladderCancerUS

[Francesca Khani, MD @FKhaniPath]

@daviesbj #catmedtwitter